bioRxiv Science⌕ Search

Biology subjects

Porter, V. L.

Publications and source records attributed to Porter, V. L..

2 recordsLinked to original sources

Allele-specific chromatin modifications of HPV-associated extrachromosomal DNAs in cervical cancer

Cervical cancer, a human papillomavirus (HPV) driven malignancy, is the fourth deadliest cancer in females. Approximately 25% of primary cervical cancers contain circular structures called extrachromosomal DNAs (ecDNAs), which can be entirely composed of human DNA (human-only ecDNAs) or a combination of HPV and human DNA sequences (HPV-human hybrid ecDNAs). Human-only ecDNAs harbour cancer-driving oncogenes, but epigenetic differences between human-only and HPV-human hybrid ecDNAs are unexplored. Here we report that 30% of cervical cancers contained at least one ecDNA. HPV-human hybrid ecDNAs contained more active enhancers and promoters than human-only ecDNAs and invariably contained the HPV oncogenes E6 and E7. These ecDNAs also contained an allelic hypomethylation region associated with putative human promoters, as well as enrichments for motifs associated with recombination hotspots. By leveraging long-read WGS phasing data to separate ChIP-seq data into alleles, we revealed allele-specific peaks in enhancers and promoters on ecDNAs, of which HPV-human hybrid ecDNAs contained a higher density. Overall, we found HPV-human hybrid and human-only ecDNAs differed in their regulation, often at an allele-specific level. Our study more firmly establishes the importance of epigenome disruption in cervical cancer and how structural variation, particularly surrounding HPV integration sites, may shape the surrounding regulatory architecture.

genomics↗

Genomic structures and regulation patterns at HPV integration sites in cervical cancer

Human papillomavirus (HPV) integration has been implicated in transforming HPV infection into cancer, but its genomic consequences have been difficult to study using short-read technologies. To resolve the dysregulation associated with HPV integration, we performed long-read sequencing on 63 cervical cancer genomes. We identified six categories of integration events based on HPV-human genomic structures. Of all HPV integrants, defined as two HPV-human breakpoints bridged by an HPV sequence, 24% contained variable copies of HPV between the breakpoints, a phenomenon we termed heterologous integration. Analysis of DNA methylation within and in proximity to the HPV genome at individual integration events revealed relationships between methylation status of the integrant and its orientation and structure. Dysregulation of the human epigenome and neighboring gene expression in cis with the HPV-integrated allele was observed over megabase-ranges of the genome. By elucidating the structural, epigenetic, and allele-specific impacts of HPV integration, we provide insight into the role of integrated HPV in cervical cancer.

genomics↗